Autoimmune Diseases
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Gain critical insights into global autoimmune disease drug development, market trends, and regulatory landscapes. Inform your pharma strategy.
Showing 1–2 of 2 articles
Quick answer
NovaPharmaNews Autoimmune Diseases hub for NMPA covers 2 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
Nektar Therapeutics pipeline update: REZPEG clinical programs and regulatory context
Biosimilar Market Growth India: Key Drivers, Challenges & Opportunities
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.